Everolimus in tuberous sclerosis patients with intractable epilepsy: A treatment option?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Everolimus in tuberous sclerosis patients with intractable epilepsy: A treatment option?

Published:2013-11 Issue:6 Volume:17 Page:631-638
ISSN:1090-3798
Container-title:European Journal of Paediatric Neurology
language:en
Short-container-title:European Journal of Paediatric Neurology

Author:

Wiegand Gert,May Theodor W.,Ostertag Philipp,Boor Rainer,Stephani Ulrich,Franz David Neal

Publisher

Elsevier BV

Subject

Neurology (clinical),General Medicine,Pediatrics, Perinatology and Child Health

Reference35 articles.

1. Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations;Curatolo;Eur J Paediatr Neurol,2012

2. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex;Zeng;Ann Neurol,2008

3. Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis;Franz;Expert Rev Anticancer Ther,2011

4. Everolimus long-term safety and efficacy in subependymal giant-cell astrocytoma;Krueger;Neurology,2013

5. Everolimus: in patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex;Curran;Paediatr Drugs,2012

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice;Orphanet Journal of Rare Diseases;2023-12-02

2. Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice;2023-08-11

3. Treatment of Pediatric Low-Grade Gliomas;Current Neurology and Neuroscience Reports;2023-03-07

4. Everolimus as a therapeutic option in refractory epilepsy in children with tuberous sclerosis: a systematic review;Arquivos de Neuro-Psiquiatria;2023-03-02

5. Therapeutic modulation of JAK-STAT, mTOR, and PPAR-γ signaling in neurological dysfunctions;Journal of Molecular Medicine;2022-12-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3